Bibliografía del artículo
1. D'Alonzo GE, Barst RJ, Ayres SM y col. Survival in patients with primary pulmonary hypertension. Results from a national prospective registry. Ann Intern Med 115:343-349, 1991.
2. Humbert M, Sitbon O, Chaouat A y col. Pulmonary arterial hypertension in France: results from a national registry. Am J Respir Crit Care Med 173:1023-1030, 2006.
3. Peacock AJ, Murphy NF, McMurray JJ, Caballero L, Stewart S. An epidemiological study of pulmonary arterial hypertension. Eur Respir J 30:104-109, 2007.
4. Kovacs G, Berghold A, Scheidl S, Olschewski H. Pulmonary arterial pressure during rest and exercise in healthy subjects: a systematic review. Eur Respir J 34:888-894, 2009.
5. Galie N, Hoeper MM, Humbert M y col. Guidelines for the diagnosis and treatment of pulmonary hypertension. Eur Respir J 34:1219-1263, 2009.
6. Pope J. An update in pulmonary hypertension in systemic lupus erythematosus - do we need to know about it?. Lupus 17:274-277, 2008.
7. Mukerjee D, St George D, Coleiro B y col. Prevalence and outcome in systemic sclerosis associated pulmonary arterial hypertension: application of a registry approach. Ann Rheum Dis 62:1088-1093, 2003.
8. Fois E, Le Guern V, Dupuy A, Humbert M, Mouthon L, Guillevin L. Noninvasive assessment of systolic pulmonary artery pressure in systemic lupus erythematosus: retrospective analysis of 93 patients. Clin Exp Rheumatol 28:836-841, 2010.
9. Shen JY, Chen SL, Wu YX y col. Pulmonary hypertension in systemic lupus erythematosus. Rheumatol Int 18:147-151, 1999.
10. Johnson SR, Gladman DD, Urowitz MB, Ibañez D, Granton JT. Pulmonary hypertension in systemic lupus. Lupus 13:506-509, 2004.
11. Arcasoy SM, Christie JD, Ferrari VA y col. Echocardiographic assessment of pulmonary hypertension in patients with advanced lung disease. Am J Respir Crit Care Med 167:735-740, 2003.
12. Pope JE, Lee P, Baron M y col. Prevalence of elevated pulmonary arterial pressures measured by echocardiography in a multicenter study of patients with systemic sclerosis. J Rheumatol 32:1273-1278, 2005.
13. Rich S, Dantzker DR, Ayres SM y col. Primary pulmonary hypertension. A national prospective study. Ann Intern Med 107:216-223, 1987.
14. Cefle A, Inanc M, Sayarlioglu M y col. Pulmonary hypertension in systemic lupus erythematosus: relationship with antiphospholipid antibodies and severe disease outcome. Rheumatol Int 31:183-189, 2011.
15. Prabu A, Patel K, Yee CS y col. Prevalence and risk factors for pulmonary arterial hypertension in patients with lupus. Rheumatology (Oxford) 48:1506-1511, 2009.
16. Rich S, Kieras K, Hart K, Groves BM, Stobo JD, Brundage BH. Antinuclear antibodies in primary pulmonary hypertension. J Am Coll Cardiol 8:1307-1311, 1986.
17. Miyakis S, Lockshin MD, Atsumi T y col. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost 4:295-306, 2006.
18. Voelkel MA, Wynne KM, Badesch DB, Groves BM, Voelkel NF. Hyperuricemia in severe pulmonary hypertension. Chest 117:19-24, 2000.
19. Williams MH, Handler CE, Akram R y col. Role of N-terminal brain natriuretic peptide (N-TproBNP) in scleroderma-associated pulmonary arterial hypertension. Eur Heart J 27:1485-1494, 2006.
20. Torbicki A, Kurzyna M, Kuca P y col. Detectable serum cardiac troponin T as a marker of poor prognosis among patients with chronic precapillary pulmonary hypertension. Circulation 108:844-848, 2003.
21. Yoshio T, Masuyama J, Mimori A, Takeda A, Minota S, Kano S. Endothelin-1 release from cultured endothelial cells induced by sera from patients with systemic lupus erythematosus. Ann Rheum Dis 54:361-365, 1995.
22. Tongers J, Schwerdtfeger B, Klein G y col. Incidence and clinical relevance of supraventricular tachyarrhythmias in pulmonary hypertension. Am Heart J 153:127-132, 2007.
23. Tunariu N, Gibbs SJ, Win Z y col. Ventilation-perfusion scintigraphy is more sensitive than multidetector CTPA in detecting chronic thromboembolic pulmonary disease as a treatable cause of pulmonary hypertension. J Nucl Med 48:680-684, 2007.
24. Torbicki A. Cardiac magnetic resonance in pulmonary arterial hypertension: a step in the right direction. Eur Heart J 28:1187-1189, 2007.
25. Kato M, Kataoka H, Odani T y col. The short-term role of corticosteroid therapy for pulmonary arterial hypertension associated with connective tissue diseases: report of five cases and a literature review. Lupus 20:1047-1056, 2011.
26. Rich S, Kaufmann E, Levy PS. The effect of high doses of calcium-channel blockers on survival in primary pulmonary hypertension. N Engl J Med 327:76-81, 1992.
27. Denton CP, Pope JE, Peter HH y col. Long-term effects of bosentan on quality of life, survival, safety and tolerability in pulmonary arterial hypertension related to connective tissue diseases. Ann Rheum Dis 67:1222-1228, 2008.
28. Heresi GA, Minai OA. Lupus-associated pulmonary hypertension: long-term response to vasoactive therapy. Respir Med 101:2099-2107, 2007.
29. Badesch DB, Hill NS, Burgess G y col. Sildenafil for pulmonary arterial hypertension associated with connective tissue disease. J Rheumatol 34:2417-2422, 2007.
30. Gonzalez-Lopez L, Cardona-Muñoz EG, Celis A y col. Therapy with intermittent pulse cyclophosphamide for pulmonary hypertension associated with systemic lupus erythematosus. Lupus 13:105-112, 2004.
31. Jais X, Launay D, Yaici A y col. Immunosuppressive therapy in lupus- and mixed connective tissue disease-associated pulmonary arterial hypertension: a retrospective analysis of twenty-three cases. Arthritis Rheum 58:521-531, 2008.
32. Hennigan S, Channick RN, Silverman GJ. Rituximab treatment of pulmonary arterial hypertension associated with systemic lupus erythematosus: a case report. Lupus 17:754-756, 2008.
33. Chung SM, Lee CK, Lee EY, Yoo B, Lee SD, Moon HB. Clinical aspects of pulmonary hypertension in patients with systemic lupus erythematosus and in patients with idiopathic pulmonary arterial hypertension. Clin Rheumatol 25:866-872, 2006.
34. Condliffe R, Kiely DG, Peacock AJ y col. Connective tissue disease-associated pulmonary arterial hypertension in the modern treatment era. Am J Respir Crit Care Med 179:151-157, 2009.